Recently, some studies reported a higher frequency of TP53, PIK3CA, and ERBB2 mutations in IBC than in non-IBC [9, 10], but these studies were performed in a small series and need further study to draw any conclusions. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.